Hereditary Prostate Cancer
Frequently Asked Questions about Hereditary Cancer
Below are some of the questions people ask about hereditary cancer genetics, screening, prevention and treatment. You can read more detailed information about risk, risk-management and treatment options here.
What is cancer?
The is a small gland that is part of the male reproductive system. It is located in the pelvis, below the bladder and near the rectum. cancer is one of the most common types of cancer that occurs in men and people assigned male at birth.
How common is cancer?
The average risk for cancer in men is about 12.8%. This means that about 1 out of 8 men will develop cancer at some point in their lifetime. Some people have a higher-than-average risk for cancer due to certain risk factors.
Who is at risk for cancer?
All people assigned male at birth are at risk for cancer; the risk varies based on multiple factors, including:
- age
- race: Black people have the highest risk for cancer of any group
- presence of an
- personal and family history of cancer
Factors such as diet, weight, exercise, smoking, alcohol consumption and environmental exposures have been studied for their effect on cancer risk with mixed results. More research is needed to understand how much these factors influence cancer risk.
Is cancer genetic?
All cancers are caused by damage to genes in the cells of the . Most of this damage happens during the course of a person's lifetime.
Some cancers are hereditary. These are caused by inherited mutations that are present at birth and can be passed on from parents to their children. Genetic counseling and testing can help people learn if they are at high risk.
Are all cancers hereditary?
About 10% of cancer is hereditary, which means it's caused by an linked to cancer risk. Genetic counseling and testing can help people learn if they are at high risk. Mutations in the genes below increase cancer risk and can cause cancer to run in families.
Genes linked to hereditary cancer risk
Mutations in the following genes have been linked to hereditary cancer.
|
Genes Linked to Cancer Risk
|
Genes Where More Research is Needed |
|
*In addition to increasing lifetime risk for cancer, is linked to an increased risk for more aggressive, disease. and may also increase the risk for an aggressive form of cancer, but more research is needed to confirm this link.
|
|
What type of cancer screening is best for high-risk people?
Experts have guidelines for screening people at high risk for cancer. These guidelines differ based on a person's age, personal and family medical history and gene mutation. Visit this page for more information.
Can an change cancer treatment options?
Yes. People with cancer who test positive for an may have additional treatment options. Some targeted therapies work better in people with certain mutations. Clinical trials testing new options may also be available. Visit this page for more information about cancer treatment options.
How are hereditary cancers different?
Hereditary cancers are more likely to occur at a young age. Some are more aggressive, and more likely to spread. Hereditary cancers may respond better to certain types of treatment. You can learn more about treatment options for hereditary cancers here.
Get notified when updated information becomes available.
SIGN UP FOR CONTENT UPDATESProstate Cancer Genetics: Experts Discuss Risk, Screening and Treatment
Study : Genes linked to aggressive prostate cancer
Previous research has linked some inherited mutations to prostate cancer risk. This study found a link to additional genes that should be added to prostate cancer gene panel tests. The...
Screening
National expert guidelines for prostate cancer screening vary based on gene mutation and other factors that affect risk.
Treatment
People diagnosed with prostate cancer may have different treatment options based on their stage and results of genetic and biomarker testing.
Genetic Testing
National guidelines outline who should consider genetic counseling and testing for an inherited mutation linked to prostate cancer.